Download Full Text (593 KB)
Juvenile idiopathic arthritis (JIA) is the most common chronic inflammatory disease seen in pediatric rheumatology. Despite advances in biologic therapy, many children with JIA will experience morbidity. Treat to Target is a treatment paradigm that involves setting a target of disease activity, using shared decision making, and incorporating clinical decision support. Our clinic aimed to set a treatment target on 50% of eligible JIA patients by December 31, 2019.
Arthritis, Juvenile; Child; Adolescent; Quality Improvement; Disease Management
Treat to Target
Pediatric Nursing | Pediatrics | Rheumatology
National Healthcare Quality Week
Harris, Julia G.; Holland, Jamie; Fox, Emily; Favier, Leslie; and Cooper, Ashley M., "Implementing Treat to Target Approach in the Care of Children with Juvenile Idiopathic Arthritis" (2019). Posters. 132.